Skip to main navigation
Skip to search
Skip to main content
Sort by
Nursing and Health Professions
Malignant Neoplasm
100%
Comorbidity
60%
Cohort Analysis
42%
Multiple Sclerosis
38%
Breast Cancer
26%
Health Service Utilisation
20%
Mental Health
20%
Prevalence
17%
Odds Ratio
16%
Health Survey
15%
Polypharmacy
14%
Diseases
14%
Cardiovascular Disease
13%
Confidence Interval
13%
Fumaric Acid Dimethyl Ester
13%
Systematic Review
13%
Meta Analysis
13%
Hazard Ratio
11%
Emergency Ward
11%
Accident Prevention
10%
Health Care Utilization
9%
Cancer Diagnosis
9%
Rate Ratio
9%
Health Status
8%
Health Condition
8%
Length of Stay
7%
Cardiovascular System
7%
Frailty
7%
Infection
7%
Mental Diseases
7%
Hospitalized Older Adults
6%
Adherence
6%
Cardiovascular Mortality
6%
Androgen Deprivation Therapy
6%
Aromatase Inhibitor
6%
Tamoxifen
6%
Prostate Cancer
6%
Premature Mortality
6%
Psychological Well-Being
6%
Scoping Review
6%
Atrial Fibrillation
6%
Drug Use
6%
Supplementation
6%
Ascorbic Acid
6%
Community Acquired Pneumonia
6%
Telehealth
6%
Patient Experience
6%
Health Literacy
6%
Multiple Chronic Conditions
6%
Hormonal Therapy
5%
Medicine and Dentistry
Multiple Sclerosis
53%
Comorbidity
53%
Diseases
34%
Breast Cancer
33%
Malignant Neoplasm
23%
Atrial Fibrillation
20%
Hazard Ratio
19%
Cohort Analysis
14%
Systematic Review
13%
Latent Class Analysis
13%
Oral
8%
Retrospective Cohort Study
8%
Cardiovascular Disease
8%
Drug Use
7%
Prevalence
7%
Meta-Analysis
7%
Mental Health
6%
Fumaric Acid Dimethyl Ester
6%
Disease Modifying Therapy
6%
Prostate Cancer
6%
Androgen Deprivation Therapy
6%
Aromatase Inhibitor
6%
Tamoxifen
6%
Immigrant
6%
Cardiovascular Mortality
6%
Womens Health
6%
Methaqualone
6%
Community-Acquired Pneumonia
6%
Ascorbic Acid
6%
Supplementation
6%
Randomized Controlled Trial
6%
Scoping Review
6%
Adverse Event
6%
Osteoporosis
5%
Pharmacology, Toxicology and Pharmaceutical Science
Multiple Sclerosis
88%
Diseases
44%
Polypharmacy
20%
Cardiovascular Disease
14%
Fumaric Acid Dimethyl Ester
14%
Adverse Event
14%
Infection
12%
Randomized Controlled Trial
12%
Comorbidity
10%
Observational Study
9%
Prevalence
8%
Alemtuzumab
7%
Interferon
7%
Breast Cancer
6%
Malignant Neoplasm
6%
Prescription Medication
6%
Methaqualone
6%
Ocrelizumab
6%
Mixed Infection
6%
Psychotropic Agent
6%
Narcotic Agent
6%
Cardiovascular Mortality
6%
Autoimmune Disease
6%
Community Acquired Pneumonia
6%
Ascorbic Acid
6%
Teriflunomide
5%
Fingolimod
5%